BIOGEN

Biogen Pharmachem Industries Ltd.

BSE: 531752

Sector: Financial Services

Industry Group: Finance

Industry: Other Financial Services

0.30+0.0 (+7.14%)

10 Aug, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

31.59

P/E (TTM)

P/B

0.32

P/S (TTM)

EV/EBITDA

CAPE (5Y)

38.56

ROE (TTM)

0.90

ROCE (TTM)

-1.68

ROA (TTM)

0.90

Avg 3Y ROE

1.33

Earnings 3Y CAGR

-27.02

Sales 3Y CAGR

Sales 5Y CAGR

Debt/Equity

0.00

Consensus TP

Strong Buy %

Promoter Holding

Pledged %

Stock Analysis

Fundamental analysis overview of Biogen Pharmachem Industries Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is cheap and PB is at a discount to industry median

PB of 0.32 indicates that the stock is cheap on a standalone basis. Discount to industry median P/B is decent at -76.12%

What is P/B Ratio?

Median: 1.34

Value 0.32

01300.2

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.0 as on 30 Jun 2026 and Debt to Equity remained same in the last 1 year

What is Debt to Equity?

Negative

Low but stable ROE

The company reported low ROE of 0.9% for 12-month ended 30 Jun 2026 and ROE improved marginally by 128 bps from 1 year ago

What is ROE (FY)?

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -109.64% for 12-month ended 30 Jun 2026 and the growth was 72.34 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Biogen Pharmachem Industries Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

ROA FY

Biogen Pharmachem Industries Ltd. Shareholding Pattern

Quarterly breakdown of Biogen Pharmachem Industries Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Indian Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00
Bodies Corporate	86.40	86.40	86.40	86.40	73.33	43.68	24.30	23.65	21.28	21.26	21.26	21.25	21.23	21.23	21.23	21.23	21.23	21.23	21.30	21.14	21.11	42.96	42.96	42.97	41.40	26.62
Others (incl. Retail) No. of shareholders	13.60 7,667	13.60 7,667	13.60 7,559	13.60 7,553	26.67 9,297	56.32 31,483	75.70 83,002	76.35 99,773	78.72 1,69,924	78.74 1,81,638	78.74 1,84,164	78.75 1,90,429	78.77 1,97,730	78.77 1,97,724	78.77 1,97,728	78.77 1,97,734	78.77 1,97,659	78.77 1,97,697	78.70 2,80,501	78.86 3,03,685	78.89 3,02,269	57.04 2,98,607	57.04 2,93,229	57.03 2,89,888	58.60 2,89,082	73.38 2,93,552

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Biogen Pharmachem Industries Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
Mohanramesh	04 May 2026	buy	₹ 0.49	51.00 lac	-
Topgain Finance Private Limited	10 Jul 2024	sell	₹ 1.30	33.55 lac	₹ 43.62 lac
Topgain Finance Private Limited	09 Jul 2024	sell	₹ 1.44	10.86 lac	₹ 15.64 lac
Topgain Finance Private Limited	09 Jul 2024	buy	₹ 1.44	44.41 lac	₹ 63.95 lac
Jai Vinayak Securities	05 Jul 2024	sell	₹ 1.70	36.20 lac	₹ 61.54 lac
Jai Vinayak Securities	05 Jul 2024	buy	₹ 1.72	32.75 lac	₹ 56.32 lac
Topgain Finance Private Limited	03 Jul 2024	sell	₹ 1.23	37.81 lac	₹ 46.50 lac
Topgain Finance Private Limited	03 Jul 2024	buy	₹ 1.23	37.81 lac	₹ 46.50 lac
Sahastraa Advisors Private Limited	03 Jul 2024	sell	₹ 1.25	32.92 lac	₹ 41.15 lac
Sahastraa Advisors Private Limited	03 Jul 2024	buy	₹ 1.23	37.79 lac	₹ 46.48 lac

…

Corporate Actions

History of Biogen Pharmachem Industries Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Bonus1 new shares for 6 existing shares
Ex-date: 15th May 2026Announced on: 23rd Mar 2026
Stock Split1 : 10
Ex-date: 29th Jul 2003Announced on: 8th Jul 2003
Nominal value change from Rs. 10 to Rs. 1

Company Profile

Overview of Biogen Pharmachem Industries Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Biogen Pharmachem Industries Limited is an India-based company, which is not engaged in any activity. The Company is looking for the right opportunity to make the Company operational.

Key personnel

Shri. Girishbhai Gatubhai Doshi

Compliance Officer

Mr. Akshay MakadiyaD

Chief Financial Officer, Executive Director

Jivan Satish KatheD

Additional Director

Ms. Aishwarya Gopalbhai ModiD

Additional Director

Mr. Rakesh Bhailalbhai PatelD

Additional Director

Mr. Rakesh TewariD

Additional Director

Mr. Udaybhai Arvindbhai PatelD

Non-Executive Director

Ms. Manishaben MuchhalaD

Independent Director

View all

Incorporated on

13 Jul 1995

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

IPO date

25 Jun 2001

Free Float

79,37,51,341

Website

Phone no.

Address

Shop No. 8, First Floor, Makers - 1 Building, Jawahar Road, RAJKOT, 360001, India

Frequently Asked Questions

What is the current share price of Biogen Pharmachem Industries Ltd.?

The current share price of Biogen Pharmachem Industries Ltd. is ₹ 0.30 as of 10 Aug 2026.

What is the market capitalisation of Biogen Pharmachem Industries Ltd.?

The market capitalisation of Biogen Pharmachem Industries Ltd. stands at ₹ 31.59 Cr.

What is the PE ratio of Biogen Pharmachem Industries Ltd.?

The Price-to-Earnings (PE) ratio of Biogen Pharmachem Industries Ltd. is - as of the latest trailing twelve months data.

What is the ROE and ROCE of Biogen Pharmachem Industries Ltd.?

Biogen Pharmachem Industries Ltd. has a Return on Equity (ROE) of 0.90% and a Return on Capital Employed (ROCE) of -1.68% as per the latest financial reports.

What is the 52-week high and low of Biogen Pharmachem Industries Ltd.?

The 52-week high of Biogen Pharmachem Industries Ltd. is - and the 52-week low is -.

What is the dividend yield of Biogen Pharmachem Industries Ltd.?

The dividend yield of Biogen Pharmachem Industries Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Biogen Pharmachem Industries Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 73.38% of Biogen Pharmachem Industries Ltd. shares.

What sector does Biogen Pharmachem Industries Ltd. belong to?

Biogen Pharmachem Industries Ltd. operates in the Financial Services sector.

What is the beta of Biogen Pharmachem Industries Ltd.?

The beta of Biogen Pharmachem Industries Ltd. is 0.06, indicating its price volatility relative to the broader market. Over the past 1 year, Biogen Pharmachem Industries Ltd. has delivered an absolute return of -61.96%.

What is the RSI of Biogen Pharmachem Industries Ltd.?

The 14-day Relative Strength Index (RSI) of Biogen Pharmachem Industries Ltd. is 47.75, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Biogen Pharmachem Industries Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Biogen Pharmachem Industries Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile